Identification of p300 histone acetyltransferase inhibitors
$47,590ZIAFY2019TRNIH
National Center For Advancing Translational Sciences
Investigators
Linked publications & trials
Abstract
The goal of this research program is to identify and develop selective small molecule inhibitors of p300 and explore their efficacy in understanding and treating these diseases. During this period, the collaborative team utilized the previously developed HTS-amenable assay to conduct the envisioned high-throughput screen for inhibitors of p300. Screening hits were identified and cherry-picked for validation, and compounds with verified activity are currently being characterized in a number of secondary assays.
View original record on NIH RePORTER →